CCL5 and pulmonary arterial hypertension: Studies have demonstrated elevated CCL5 expression in the lung tissue and peripheral blood of pulmonary arterial hypertension (PAH) patients, which correlates with deteriorating cardiac function and adverse prognosis [28, 29].